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High-resolution analysis of multi-copy
variant surface glycoprotein gene
expression sites in African trypanosomes
Sebastian Hutchinson1, Lucy Glover1,2 and David Horn1*
Abstract
Background: African trypanosomes cause lethal diseases in humans and animals and escape host immune attack
by switching the expression of Variant Surface Glycoprotein (VSG) genes. The expressed VSGs are located at the
ends of telomeric, polycistronic transcription units known as VSG expression sites (VSG-ESs). Each cell has many
VSG-ESs but only one is transcribed in bloodstream-form parasites and all of them are inactive upon transmission
to the insect vector mid-gut; a subset of monocistronic metacyclic VSG-ESs are then activated in the insect
salivary gland. Deep-sequence analyses have been informative but assigning sequences to individual VSG-ESs
has been challenging because they each contain closely related expression-site associated genes, or ESAGs,
thought to contribute to virulence.
Results: We utilised ART, an in silico short read simulator to demonstrate the feasibility of accurately aligning
reads to VSG-ESs. Then, using high-resolution transcriptomes from isogenic bloodstream and insect-stage Lister
427 Trypanosoma brucei, we uncover increased abundance in the insect mid-gut stage of mRNAs from metacyclic
VSG-ESs and of mRNAs from the unusual ESAG, ESAG10. Further, we show that the silencing associated with allelic
exclusion involves repression focussed at the ends of the VSG-ESs. We also use the approach to report relative fitness
costs following ESAG RNAi from a genome-scale screen.
Conclusions: By assigning sequences to individual VSG-ESs we provide new insights into VSG-ES transcription control,
allelic exclusion and impacts on fitness. Thus, deeper insights into the expression and function of regulated multi-gene
families are more accessible than previously anticipated.
Keywords: Allelic exclusion, Antigenic variation, Gene expression, RNA-seq, Trypanosoma brucei, VSG
Background
African trypanosomes are protozoan parasites that
cause devastating diseases known as human African
trypanosomiasis and a livestock disease known as
nagana. These parasites are transmitted by the bite of
an infected tsetse-fly, the distribution of which restricts
the geographic spread of the disease. The parasite exists
extracellularly, and is continually exposed to immune
attack in the mammalian host [1]. To persist in the host
bloodstream, the parasite has evolved a sophisticated
strategy of antigenic variation and immune evasion.
The trypanosome surface is coated in a dense layer of
107 copies of a single variant surface glycoprotein
(VSG) [2]. Switching of this VSG coat is central to
adaptive immune evasion, and operates at a rate of ap-
proximately 10−6 per parasite cell division in culture
[3]. In vivo, this leads to the recrudescent parasitaemia
characteristic of T. brucei infection [1], where un-
switched parasites are removed by antibody mediated
killing.
VSG expression sites (VSG-ESs) are the key subtelo-
meric polycistronic units involved in antigenic vari-
ation in bloodstream African trypanosomes [4].
Understanding the expression and function of these
units is critical to understanding virulence. VSG-ES
transcription, mediated by RNA polymerase I, initiates
at multiple VSG-ES promoters but is attenuated in all
but one to prevent multi-VSG expression in individual
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cells [5]. The polycistronic VSG-ESs contain a number
of Expression Site Associated Genes (ESAGs), several
of which are of unknown function, but those that have
been characterised are involved in nutrient acquisition;
ESAG6 and ESAG7 [6], and innate immune evasion;
ESAG4 and SRA [7, 8]. In trypanosomes, maturation of
mRNA from nascent transcripts occurs via the linked pro-
cesses of trans-splicing, the addition of a 39-nt capped
leader sequence, and poly-adenylation [9, 10]. RNA Pol-II
transcribes the spliced leader from a repetitive array as a
primary 135 b transcript [11], that is processed and 5′
capped before association with the spliceosome [12],
which mediates trans-splicing to nascent transcripts [10].
Antigenic variation is specifically required for immune
evasion in the bloodstream and, consistent with this,
VSG-ESs are subject to developmental regulation. Upon
parasite differentiation in the tsetse mid-gut,VSG tran-
scription stops and the VSG coat is shed in the fly mid-
gut, where recent evidence shows it interferes with fly
innate immunity [13]. Procyclins, a family of repetitive
proteins containing either EP or GPEET amino acid
repeats, replace the VSG coat in the mid-gut [14]. Fol-
lowing migration to the fly salivary gland, a distinct
sub-set of VSGs are expressed on the surface of metacyclic
cells from monocistronic VSG-ESs, and are required for
re-infection of the mammalian host [15, 16].
Next-generation sequencing (NGS) and RNA-seq
approaches in particular, have been used in African
trypanosomes to examine a range of features of gen-
ome organisation and gene expression, including
developmentally regulated transcript expression [17],
alternative splicing [18], control by RNA-binding proteins
[19] and translation control [20, 21]. The approach has
also been used to analyse relative expression levels for
transcripts mapping to the active VSG-ES, revealing that
most ESAG transcripts are present at 1–0.01 % the level
of the active VSG transcript [17, 18].
NGS analysis of VSG-ESs presents several unique
challenges. In particular, VSG-ESs are closely related
[22] and, although increased mapping stringency can
improve the alignment [23], the accuracy of assigning
sequence-reads to the correct and specific sites has not
been assessed in detail. Genes related to ESAGs (GRE-
SAGs) are also found at non-telomeric locations; copies
of GRESAG4 are particularly prevalent and copies of
GRESAG2 are present at procyclin loci [24, 25]. In
addition, VSG-ESs are under-represented in reference
genome-sequence assemblies. Fortunately, the full set
of VSG-ESs have been isolated and sequenced [22],
and the subset of VSG-ESs expressed in the metacyclic
stage has also been identified [15, 26], in the widely
studied Lister 427 strain. However, developmental con-
trol of VSG-ESs has not yet been analysed in any detail
in this strain.
We generated transcriptome data from sub-cloned
populations of Lister 427 cells expressing a defined VSG
(VSG-2) and from differentiated insect mid-gut stage
cultures directly derived from those sub-clones. We then
developed computational approaches to determine how
accurately short reads derived from NGS can be aligned
to VSG-ESs. We find that the differences between VSG-
ESs are sufficient to allow 100-b reads to be accurately
aligned to specific loci. Subsequent high-stringency
mapping revealed a number of unanticipated features
regarding VSG-ESs and their developmental control.
High-stringency mapping was also applied to published
NGS datasets. This revealed specific perturbations to
VSG-ES transcriptomes following knockdown or over-
expression of the allelic exclusion regulator VEX1 [27],
and relative fitness costs following knockdown of indi-
vidual ESAGs [28].
Results
Transcriptomes from isogenic bloodstream and
insect-stage T. brucei
We derived transcriptomes from a pair of Lister 427
bloodstream form sub-clones expressing VSG-2 and
from directly derived, differentiated, insect-stage cul-
tures, separated from the bloodstream form sub-clones
by only 10 days. Since the core, non sub-telomeric por-
tion of the TREU-927 reference and Lister 427 genomes
are closely related, sequence reads were aligned to the
11 megabase chromosomes from the TREU-927 genome
[29], plus a non-redundant set of the 14 VSG-ESs [22]
and 5 metacyclic VSG-ESs [15] from the Lister 427
strain. We aligned 26.4 and 26.5 million bloodstream
form and 49.9 and 53.5 million insect-stage, 100 b,
paired end reads using Bowtie2 [30], yielding approxi-
mately 180x genome coverage for bloodstream form and
350x for insect-stage transcriptomes. We calculated reads
per kilobase of transcript per million mapped reads
(RPKM), and differential expression using edgeR [31]; an
additional table file shows these values (Additional file 1,
‘BSF v PCF mapq > 0’ tab). This revealed excellent repro-
ducibility between clones, Pearson correlation coefficients
of > 0.99 (Additional file 2), and robust developmental
control of known bloodstream-form and insect-stage
specific genes (Fig. 1a). For example, upon differenti-
ation, the EP and GPEET procyclins increased 306 (EP1
and EP2 average) and 153-fold, respectively, while
VSG-2 decreased 1.2 × 106 fold; BES1 ESAG transcripts
were also decreased (Fig. 1a). In addition, phosphoglyc-
erate kinase A (PGKA) displayed little change while
PGKB increased (3.3-fold) and PGKC decreased (4.7-
fold), as expected [32].
We next analysed reads from bloodstream and insect-
stage cells that aligned to the active VSG-ES. A single
base resolution BES1 plot (Fig. 1b) revealed a strikingly
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compact transcription-unit, incorporating little inter-
transcript DNA sequence. Reads associated with a
trans-spliced leader sequence, found associated with all
trypanosomatid mRNAs [10], revealed trans-splicing at
discrete points for each gene (Fig. 1b), as expected [33].
We observed multiple trans-splicing events within the
VSG gene, but the dominant splice-site was used
>1000-fold more frequently than other sites. As also ex-
pected, we see bloodstream-specific over-representation
(266 fold on average) of transcripts for every ESAG
present in the active VSG-ES (Fig. 1b), consistent with
transcription attenuation following differentiation [34].
In the bloodstream-form, the VSG transcript itself is
141-fold more abundant than the mean value of the
other VSG-ES-derived transcripts. We do see some iso-
lated ESAGs that display higher expression relative to
upstream ESAGs following differentiation to the insect
stage but, rather than VSG-ES internal transcription
initiation, this likely reflects incorrect assignment of
reads from GRESAGs that are transcribed by RNA pol-
II [24, 25]. Analysis of procyclin loci (also transcribed
by RNA Pol-I) and the PGK locus (transcribed by RNA
Pol-II) revealed similarly compact transcription units
and the expected developmental controls (Fig. 1b).
Thus, our RNA-seq datasets from isogenic bloodstream
and insect-stage cultures are suitable for more detailed
VSG-ES transcriptome analysis.
‘Short’ reads can be accurately assigned to VSG-ESs
We next considered the challenge of accurately assigning
100-b sequence reads from RNA-seq datasets to individ-
ual VSG-ESs. Analysis of ESAG7 genes from the Lister
0.01
0.1
1
10
100
1000
10000
100000
0.01 1 100 10000
Genome
VSG-2
BES1 ESAGs
Procyclins
PGK
In
se
ct
 R
P
K
M
Bloodstream RPKM
a
b
GPEET2
EP1
EP2
PGK A
PGK B
PGK C
R
P
M
R
P
M
R
P
M
R
P
M
Fig. 1 T. brucei transcriptomes from isogenic bloodstream and insect stage cultures. a The scatter plot shows RNA-seq data for bloodstream form
and insect stage cultures. Values are calculated as RPKM (Reads Per Kilobase of transcript per Million mapped reads) and are averages for a pair of
independent sub-clones. Selected developmentally regulated genes are highlighted. b Base-pair resolution plots of the active VSG-ES (top panel),
GPEET2 and EP1/EP2 loci (middle panels) and the phosphoglycerate kinase locus (lower panel). Read counts are normalised using reads per million
mapped (RPM) and trans-spliced reads are also indicated. Beneath each panel is a schematic map for each locus. Boxes, coding sequences;
arrowsheads, Pol-I promoters
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427 strain highlighted the challenge in terms of distin-
guishing among individual ESAGs (Additional file 3). In
this case, a high level of identity was observed through-
out the coding-sequence. There are differences however,
which can be exploited.
In order to determine the feasibility of accurate short
read alignment to VSG-ESs, we used ART [35] to simu-
late the Illumina sequencing platform in silico and to
generate 105 single end, 100-b reads derived exclusively
from individual VSG-ESs. We initially simulated Illu-
mina sequencing runs of the sequence isolated from the
active VSG-ES in our experimental strain and from three
additional VSG-ESs (Fig. 2a). These reads were then
aligned to the VSG-ES sequences using Bowtie2 [30],
with the same settings used above. We observed reads
aligning inappropriately to other VSG-ESs, however the
signal to noise ratio could be increased significantly by
filtering reads by the uniqueness (MapQ value) of the
alignment, assigned to each read by Bowtie2 (Fig. 2a).
This filters reads with a higher probability of being mis-
aligned to the genome. We went on to repeat this in
silico analysis with the entire set of assembled blood-
stream and metacyclic VSG-ESs from the Lister 427
strain (Fig. 2b).
The analysis indicated that Bowtie2 aligns 75.5 % of
in silico generated reads to the correct bloodstream
VSG-ES with a MapQ > = 0 (98.7 % to metacyclic VSG-
ESs) such that mis-aligned reads, as expected, can have
a significant negative impact on transcriptome analysis.
A MapQ value of > 1 removes 99.9 % of inappropriately
aligned reads and retains 81 % of the signal while a
MapQ > 12 eradicated all noise from the data and
retained 65.7 % of the signal (Fig. 2b). We selected a
MapQ cutoff > 1 as optimal for accurately assigning
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Fig. 2 Simulations identity the optimal MapQ setting for accurate VSG-ES mapping. a. In silico reads generated from the ART program for a
subset of VSG-ESs were aligned to the genome; only the VSG-ESs are shown on a linear scale. Varying the MapQ value (either no filter – 0, or
incrementally > 1, > 10, > 40) to filter non-uniquely mapping reads improves the signal to noise ratio. mVSG, metacyclic VSGs. Beneath each
panel is a schematic map for each locus. Boxes, coding sequences; arrowsheads, Pol-I promoters. Red reads BES1, Green reads BES5, Orange
reads BES14, Blue reads BES15. b Analysis of all VSG-ESs using the ART method. Plots show reads derived from each contig, and aligned to the
genome; only genes in VSG-ESs are shown. MapQ > 12 is the lowest value at which no noise is detected. Metacyclic VSGs are on the left
Hutchinson et al. BMC Genomics  (2016) 17:806 Page 4 of 11
short sequence reads to individual VSG-ESs; the vast
majority of VSG-ES associated genes retain short reads
using this approach; an additional table file shows these
values (Additional file 1, ‘BSF v PCF mapq > 1’ tab).
During this analysis, we also observed a distinct trend
in the distribution of in silico-generated reads. Specific-
ally, reads were more effectively retained closer to the
telomere as we increased the uniqueness of alignment
(Additional file 4A), indicating that sequences closer to
telomeres are more divergent/unique. The alignment map
for promoter-proximal ESAG7 genes from Additional file
3 is also compared to an alignment map for the telomere-
proximal ESAG1 to further illustrate this point (Additional
file 4B). Although a contested hypothesis [36], error-
prone VSG gene-conversion was previously suggested
as a mechanism contributing to antigenic variation
[37, 38]. Our observation is consistent with this
hypothesis when taken together with the inherent fra-
gility of sub-telomeres and subsequent telomere-
directed gene-conversion events [39].
Differential controls affecting specific ESAGs and VSGs
Using a MapQ > 1, we filtered our RNA-seq data for
high-confidence read alignments to VSG-ESs. The
major developmental changes reported above (Fig. 1a)
were also observed for this filtered dataset (Additional
file 5). Filtering allowed us to assign reads to ‘silent’
VSG-ESs (Fig. 3a-b) and this revealed transcripts ori-
ginating from the majority of VSGs in bloodstream-
form cells (Additional file 5). This may reflect low-level
expression of other VSG-ESs in cells expressing VSG-2
or may equally reflect low-frequency activation of alter-
nate VSG-ESs. Since our RNA samples were prepared
using approximately 100 million cells and switching
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Fig. 3 VSG-ES transcriptomes reveal unexpected features. a Base-pair resolution plots of six silent VSG-ESs containing ESAG10 (blue boxes). Read
counts were normalised using RPM. Beneath each panel is a schematic map for each locus. Boxes, coding sequences; arrowsheads, Pol-I promoters.
Red lines, bloodstream-form; blue lines, insect-stage. b Box plot showing fold-change (log scale) from bloodstream to insect stage, of active and silent
ESAGs grouped by type and position in VSG-ESs according to [22]. c Base-pair resolution plots of all five metacyclic-specific VSG-ESs. Red lines,
bloodstream-form; blue lines, insect-stage. d Box plot showing fold-change (log scale) from bloodstream to insect stage, of bloodstream
(bVSG) and metacyclic (mVSG) VSGs
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occurs in approximately one in every 106 cells, we ex-
pect approximately 100 distinct switching events to be
represented, although this does not so readily explain
the expression of metacyclic VSG genes. As transcrip-
tion is initiated at all VSG-ESs [5], proximity to the
promoter may explain this low-level transcription of
metacyclic VSGs that we observe in bloodstream form
cells (Fig. 3c).
Reads mapping to ‘silent’ VSG-ESs are 2.4 × 104-fold
lower on average relative to those mapping to the active
VSG-ES and are further reduced when cells differentiate
to the insect stage (Fig. 3a). Again, we see some isolated
ESAGs that display higher expression relative to up-
stream genes, likely reflecting reads from RNA pol-II
transcribed GRESAGs [24, 25]. VSG-ESs share a generic
structure, with similar ESAGs in similar positions. When
grouped and represented according to their position,
VSG-ES associated genes closer to telomeres display
greater down-regulation in the insect-stage (Fig. 3b). For
instance, average VSG expression level decreases 21-
fold upon differentiation to insect stage cells, while
ESAG7 expression decreased only 2 fold. In contrast to
other ESAGs, four of six ESAG10 genes were signifi-
cantly (p < 0.05) upregulated (average 3.9 fold) in the
insect-stage (Fig. 3a-b). This was unexpected since
ESAG expression has been considered bloodstream
stage-specific [40]. Thus, ESAG10 may be an unconven-
tional ESAG in terms of developmental expression-
control.
Another unexpected observation was that, while VSGs
in polycistronic VSG-ESs were down-regulated, three of
the five VSGs located within the monocistronic metacyc-
lic VSG-ESs were expressed at a significantly higher level
(8.4 fold average, p < 10−22) in insect-stage cells (Fig. 3c-d,
Additional file 5). VSG expression has been considered to
be specific to the tsetse salivary gland stage and the
bloodstream-stages, due to promoter control (the VSG-ES
promoters active in bloodstream-form cells are distinct
from the VSG promoters active in metacyclic cells) and
stage-specific stabilisation of transcripts driven by a con-
served element in the VSG mRNA 3′ untranslated se-
quence [41]. We speculate that the unexpected increase in
expression of monocistronic metacyclic VSGs reflects pro-
gression to a metacyclic (−like) stage by small numbers of
cells present in differentiated cultures. Indeed, increased
expression of a single RNA binding-protein, RBP6, can
trigger this progression through the life cycle [15]. Alter-
natively, sub-telomeric silencing may be less pronounced
in insect-stage cells.
Our analysis of silent VSG-ESs allowed us to identify
the trans-splicing sites for twelve VSG-ES linked VSGs
and all five metacyclic VSGs from our RNA-seq data
(Additional file 6A-B). We counted polypyrimidine tract
lengths for VSG splice sites and compared these to the
genes in the RNA Pol-I transcribed procyclin loci, count-
ing the number of consecutive pyrimidines and allowing
for a single purine interruption. We found that the VSG
genes are associated with significantly shorter polypyri-
midine tracts (11.5 b, n = 17) compared to genes in the
procyclin loci (19.0 b, n = 13, p < 4 × 10−4) or the 20
most abundant RNA Pol-II transcripts in our dataset
(20.4 b, n = 20, p < 5 × 10−4) (Additional file 6C). Not-
ably, ESAG7 genes also possess shorter polypyrimidine
tracts, suggesting that VSG-ES associated genes do not
require extensive polypyrimidine tracts to form abundant
mature messenger RNAs. Identification of splice-sites also
allowed us to predict 5′-untranslated sequences and we
note that there does not appear to be a consensus here;
these sequences range in size from 15 to 91 b.
Regulation of VSG-ES transcripts by VEX1
VEX1 (VSG exclusion 1) is an allelic exclusion regulator
required for the control of VSG gene expression [27]. In
order to further our understanding of control by VEX1,
we analysed the RNA-seq datasets generated following
VEX1 overexpression (Fig. 4a) or RNAi knockdown
(Fig. 4b), which both lead to increased expression of
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Fig. 4 VSG-ES transcriptome analysis following VEX1 perturbation.
a Average change of ‘generic’ [22] ESAG expression at either active
(red) or silent (blue) VSG-ESs following overexpression of VEX1. b As
in A but showing change in gene expression following knockdown
of VEX1. Beneath each panel is a schematic map for each locus.
Boxes, coding sequences; arrowsheads, Pol-I promoters. Black line
crosses at 1 fold change (no change in expression)
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‘silent’, ES-associated VSG genes [27]; an additional table
file shows these values (Additional file 1, ‘VEX1’ tabs).
High confidence (MapQ > 1) read alignments, of genes
with > 10 reads when VEX1 was overexpressed, revealed
an average of 5.4 fold more active VSG-ES ESAG tran-
scripts, with 77 % of genes tested significantly increasing
(> 3 fold change, p < 0.05) (Fig. 4a, Additional file 7, red
bars), and an average 93-fold increase in silent ESAG
transcripts, with 86 % of genes tested increasing signifi-
cantly (> 3 fold change, p < 0.05) (Fig. 4a, Additional file 7,
blue bars). These results are consistent with the previously
reported positive control by ectopically expressed VEX1
[27].
We next analysed the RNA-seq data derived following
VEX1 RNAi (Fig. 4b, Additional file 7). In this case, our
analysis shows minimal impact at the active VSG-ES
(Fig. 4b, red bars) but differential behaviour of the ‘si-
lent’ VSGs and the ESAGs at either end of VSG-ESs
relative to the centrally located ESAGs. Specifically, the
promoter-adjacent ESAG6 and 7 were increased 10-
fold; 75 % of genes tested increasing significantly (> 3
fold, p < 0.05), while the telomere-proximal VSG and
ESAG1 increased 10 to 15-fold; 50 % of genes tested in-
creasing significantly (> 3 fold, p < 0.05). This is in con-
trast to several centrally located ESAGs, which
increased only 1.5 fold on average, with just 2 % of
genes tested increasing significantly (> 3 fold, p < 0.05).
Loss-of-fitness associated with ESAG knockdown
Our understanding of the functions of the ESAGs re-
mains incomplete and, because of difficulties with accur-
ate mapping as outlined above, the ESAGs were not
analysed as part of prior high-throughput phenotyping
analysis using RNA interference (RNAi) in in vitro cul-
ture [28]. We revisited these data and mapped RIT-seq
reads (MapQ > 1) from bloodstream and insect stage
cells to the VSG-ES active in the bloodstream-form
(Fig. 5a); an additional table file shows these values
(Additional file 1, ‘BES1 RIT-seq’ tab). Although the
RNAi library used in the Lister 427 strain was derived
from the TREU 927 strain, the closely related RNAi tar-
get fragments are still expected to mediate efficient
ESAG knockdown [42]. Mapped reads were quantified
and analysed relative to the uninduced control (Fig. 5b)
revealing loss-of-fitness following ESAG2, ESAG3 and
ESAG8 RNAi that achieved significance following
ESAG2 RNAi; other ESAGs failed to register a loss-of-
fitness. A previous study reported loss-of-fitness for
every ESAG knockdown tested [43] but ESAG2 also reg-
istered the greatest loss-of-fitness in that study. This
phenotype may reflect the knockdown of RNA pol-II
transcribed GRESAG2 transcripts [24, 25] rather than
VSG-ES associated ESAG2 transcripts, however. None of
the ESAGs, except for ESAG8, registered a loss-of-fitness
in the insect-stage, consistent with developmental stage-
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specific ESAG expression. Notably, several ESAGs may
be specifically required for host-parasite interactions,
functions that are dispensable in in vitro culture.
Discussion
Massive parallel NGS approaches have revolutionised
the study of gene regulation and expression, producing
data with an unrivalled depth [44], and have been ap-
plied with great success in African trypanosomes; see
[17, 18, 33] for just a few examples. There are, however,
a number of challenges associated with the analysis of
subtelomeric sequences in a range of eukaryotes. These
regions often incorporate highly repetitive and plastic
components of the genome. This is particularly true of
parasites, in which subtelomeric genes function in the
processes of antigenic variation and immune evasion, such
as malaria parasites [45] and African trypanosomes [4].
Analysis of these repetitive loci has proven challen-
ging, a fact exemplified by our in silico analyses. Indeed,
we note the use of orthogonal methods such as qRT-
PCR and genetic tagging of VSG-ESs [46, 47], despite
the availability of NGS approaches and datasets. We
now report high-coverage transcriptomes from isogenic
T. brucei cultures and from two major life cycle stages,
namely the mammal-infective bloodstream form and the
tsetse fly mid-gut stage, with a focus on the regulation
of VSG-ES transcription. Simulated Illumina sequence
data allowed us to gauge an appropriate filter that maxi-
mises the signal-to-noise ratio of sequence alignments at
these loci. We find the expected extreme developmental
regulation of VSG and EP/GPEET surface antigen genes
and VSG-ES attenuation in insect stage cells but also,
using high-stringency mapping, uncover additional and
unexpected features.
Previous reports indicate that alignment of short reads
to VSG-ESs can be problematic due to the similarity be-
tween these loci [22, 46, 48]. Our analyses show that an
average of 24.5 % of VSG-ES derived reads are typically
incorrectly aligned to VSG-ESs, and filtering reads with
a MapQ value > 1 greatly reduces mis-mapping. Further
analyses of VSG-ESs suggest that this is particularly use-
ful for the closely related ESAG sequences. Improve-
ments in sequencing technologies, such as quality (our
sequence data has mean per-base quality scores > 34)
and read-length now facilitate accurate high-stringency
mapping. Specifically, we believe that 100–150 b reads
that are commonly produced by current Illumina tech-
nologies incorporate sufficient SNPs to allow specific
assignment to individual VSG-ESs.
In bloodstream cells, monoallelic expression ensures
that a single subtelomere is productively transcribed [1].
However, in mid-gut stage cells, VSG-ESs are silenced
[34]. In our populations, we find that transcripts for
twelve silent VSG-ES linked and all five metacyclic VSGs
are detectable, although at a level approximately 26,000
times lower than the active VSG; illustrating the impres-
sive dynamic range of RNA-seq. In addition, our analysis
reveals that ESAG10 mRNAs, encoding putative folate
transporters [49], are more abundant in the mid-gut
stage cultures than the bloodstream form. This surpris-
ing finding is suggestive of less effective silencing in the
insect-stage of ESAG10-associated VSG-ES promoters
relative to the almost identical VSG-ES promoters
located downstream [22]. Alternatively, ESAG10 tran-
scripts may display increased stability in insect-stage
cells. Notably, additional RNA pol-II transcribed genes
on chromosome 8 (Tb927.8.3620, 3630 and 3650)
encode folate transporters and whether the ESAG10-
associated promoters or transcripts are ‘activated’ at
any point in the life cycle remains unknown.
High-stringency mapping using transcriptomic data-
sets derived following knockdown of the allelic exclusion
regulator, VEX1 [27], revealed derepression of promoter
and telomere proximal VSG-ES genes. In another study,
ectopic overexpression of a second VSG gene resulted in
VSG-ES silencing spreading from the telomere towards
the promoter in a disruptor of telomeric silencing 1B
(DOT1B) dependent manner [43]. Our analysis indicates
that VEX1-mediated silencing is directed at the telo-
meric VSG and ESAG1 genes, and at the VSG-ES
promoter-adjacent ESAG6 and ESAG7 genes. This is in
contrast to VEX1 overexpression, which upregulates all
silent ESAGs and VSGs. Thus, our current data indicate
that VEX1-mediated silencing primarily affects the ends
of silent VSG-ESs, suggesting that subtelomere conform-
ation may be important in the control of these genes.
Finally, high-stringency phenotyping data confirm
(GR)ESAG2 as the ESAG associated with the greatest fit-
ness cost when knocked-down in in vitro culture.
Conclusions
By distinguishing between closely related transcription
units, we have been able to enhance our understanding
of the behaviour of VSG-ESs in terms of VSG silencing,
developmental regulation and contributions to fitness in
culture. NGS approaches, coupled to high-stringency
mapping, such as RNA-seq, ChIP-seq, RIT-seq and the
growing list of ‘seq’ technologies will undoubtedly im-
prove our understanding of the organisation and expres-
sion of these virulence gene loci and indeed closely
related gene families in a range of other organisms.
Methods
T. brucei
Two subclones of wild type bloodstream-form Lister 427
strain T. brucei expressing VSG-2 (VSG-221, Mitat1.2) were
differentiated to insect mid-gut stage cells as previously de-
scribed [50]. Briefly, cells were collected by centrifugation
Hutchinson et al. BMC Genomics  (2016) 17:806 Page 8 of 11
and resuspended in differentiation medium (DTM) [50]
supplemented with 3 mM citrate and 3 mM cis-aconitate
and maintained for 10 days at 27 °C, 0 % CO2 (ambient).
RNA-seq
For RNA extraction, 5 × 107 cells were collected and
RNA prepared using the Qaigen RNeasy kit, according
to the manufacturer’s instructions. Poly-A+ RNA was
enriched using oligo-dT beads, and reverse transcribed.
Second strand synthesis was randomly primed. Sequen-
cing was performed on the HiSeq platform (Illumina) at
the University of Dundee generating 100-b paired-end
reads. This yielded insect-stage RNA-seq data, using
identical processing, that were only 10-days removed
from our bloodstream-form RNA-seq data [27].
In order to align reads we generated a hybrid genome
assembly consisting of the 11 megabase chromosomes
from the T. brucei 927 reference genome [29], the non-
redundant set of 14 bloodstream expression sites [22]
and the 5 metacyclic expression sites from our Lister
427 strain [15, 26]. Read alignment was performed
using Bowtie2 [30] as previously described [27] using
the parameters –very-sensitive –no-discordant. Ap-
proximately 25 million bloodstream-form and 50 mil-
lion insect stage reads were aligned for each clone.
Alignment files were manipulated using SAMtools [51],
and visualized in the Artemis genome browser [52].
Single base resolution plots were generated using the
pysam API (https://github.com/pysam-developers/pysam)
in an in-house script that filters reads based on alignment
quality (MapQ) and corrects for library size (available on
request). Trans-spliced reads were extracted using a previ-
ously published script [53], using the partial spliced leader
sequence ‘TCTGTACTATATTG’ and it’s reverse comple-
ment to search. This is the shortest sequence that returns
only spliced leader sequences following BLAST search of
the TREU-927 genome sequence on TriTrypDB. Differen-
tial expression analysis was performed with edgeR [31] as
previously described [27]. When analysing VEX1 perturb-
ation, we excluded genes with <10 reads averaged across
replicates in both uninducing or inducing conditions.
ART simulation
ART is a software package that simulates next-generation
sequencing runs using empirical error models utilized by
the 1000 genomes project [35]. Illumina sequencing runs
were simulated for all 19 of the Lister 427 VSG-ES contigs
in the hybrid genome using the parameters art_illumina -i
contigX.fa -len 100 -ss MS -c 100000. This produced 105
single-end reads for each contig; as the longest contig is
59,781 bp, this provided coverage of every base in each
VSG-ES. These in silico reads were then aligned back to
the complete genome with Bowtie2 using the parameters
–very-sensitive [30]. Alignment files were manipulated
using SAMtools [51]. Read counts were generated using
the Artemis genome browser [52].
Sequence and data analysis
Clustal alignment analysis and visualisation of ESAG7
sequences was performed using CLC workbench using
settings: gap open cost = 0.0, gap extension cost = 0.0, end
gap cost = free, alignment mode = very accurate, redo
alignments = no, use fixedpoints = yes. A non-redundant
gene list was from [28] and VSG-ES sequences [22] were
retrieved from TriTrypDB. ‘Generic’ ESAG lists are de-
rived from [22]; ESAGs from each VSG-ES were compiled
based on relative position within each VSG-ES.
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